India Hyperglycemics Research
10 comprehensive market analysis studies and research reports on the India Hyperglycemics sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 79 companies, enriched with industry statistics, insights, and a lot more.
TRENDING REPORTS
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market
CAGR: 4.27%
Study Period: 2020 - 2031
Middle East And Africa Insulin Market
CAGR: 3.73%
Study Period: 2020 - 2031
Middle East And Africa Meglitinide Market
CAGR: 4%
Study Period: 2019 - 2030
North America Meglitinide Market
CAGR: 1.5%
Study Period: 2019 - 2030
Europe Meglitinide Market
CAGR: 2.30%
Study Period: 2019 - 2030
Healthcare
Categories
10 Healthcare Reports
Categories
Showing 10 of 10 results in Hyperglycemics
Biguanides Market
CAGR: 2.22%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: India
Major Players:Bristol-Myers Squibb, Glenmark Pharmaceuticals, Takeda Pharmaceuticals, Sanofi, Merck
Starting at:$4,750
Asia-Pacific Sodium-dependent Glucose Cotransporter 2 Market
CAGR: 7.94%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: India
Major Players:Eli Lilly and Company, Boehringer Ingelheim, Janssen, AstraZeneca, Bristol-Myers Squibb
Starting at:$4,750
Insulin Market
CAGR: 3.62%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: India
Major Players:Novo Nordisk, Eli Lilly and Company, Pfizer, Sanofi, Biocon Biologics Ltd.
Starting at:$4,750
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Market
CAGR: 8.05%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: India
Major Players:Janssen, Boehringer Ingelheim, Eli Lilly and Company, Astellas Pharma, AstraZeneca
Starting at:$4,750
APAC Meglitinide Market
CAGR: 1.7%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: India
Major Players:Novo Nordisk, Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon
Starting at:$4,750
APAC Biguanide Market
CAGR: 2%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: India
Major Players:Takeda Pharmaceuticals, Bristol-Myers Squibb, Glenmark Pharmaceuticals, Merck, Sanofi
Starting at:$4,750
Insulin Glargine Market
CAGR: 6.05%
Study Period: 2020 - 2031
Starting at:$4,750
Country Covered: India
Major Players:Sanofi, Novo Nordisk, Biocon, Eli Lilly and Company, Julphar
Starting at:$4,750
Sulfonylureas Market
CAGR: 3.12%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: India
Major Players:Sanofi, Pfizer, Merck, Torrent Pharmaceuticals, Dr. Reddy’s Laboratories
Starting at:$4,750
Meglitinide Market
CAGR: 2.21%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: India
Major Players:Glenmark Pharmaceuticals, Novartis, KISSEI PHARMACEUTICAL, Biocon, Novo Nordisk
Starting at:$4,750
Asia-Pacific Insulin Therapeutics Market
CAGR: 2.54%
Study Period: 2019 - 2030
Starting at:$4,750
Country Covered: India
Major Players:Novo Nordisk, Eli Lilly and Company, Sanofi, Biocon, Gan & Lee
Starting at:$4,750
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.
